Shariah compliance overview
HalalNovo Nordisk A/S (NVO) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Novo Nordisk A/S
Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint.
Novo Nordisk A/S (NVO) operates in the Healthcare sector, in the Drug Manufacturers - General industry.
Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 0.41% (limit 5%), interest-bearing debt is 4.86% (limit 30%) and interest-bearing securities and assets are 1.07% (limit 30%).
If you hold NVO, give 0.41% of the dividends you receive to charity to purify the non-compliant share of its income.
- Business Activity
- 0.41%Limit 5%Pass
- Interest-bearing debt
- 4.86%Limit 30%Pass
- Interest-bearing securities and assets
- 1.07%Limit 30%Pass
- Dividend purification
- 0.41%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Novo Nordisk A/S (NVO). Current Akinda screening label: Halal.
